PortfoliosLab logoPortfoliosLab logo
EDIT vs. BLUE
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

EDIT vs. BLUE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Editas Medicine, Inc. (EDIT) and bluebird bio, Inc. (BLUE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

EDIT vs. BLUE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EDIT
Editas Medicine, Inc.
20.49%61.42%-87.46%14.21%-66.59%-62.13%136.78%30.15%-25.97%89.34%
BLUE
bluebird bio, Inc.
0.00%-40.41%-69.78%-80.06%-30.73%-64.35%-50.69%-11.54%-44.30%188.65%

Fundamentals

Total Revenue (TTM)

EDIT:

$40.52M

BLUE:

$103.95M

Gross Profit (TTM)

EDIT:

$39.72M

BLUE:

$28.19M

EBITDA (TTM)

EDIT:

$0.00

BLUE:

-$115.82M

Returns By Period


EDIT

1D
10.76%
1M
12.27%
YTD
20.49%
6M
-28.82%
1Y
112.93%
3Y*
-30.16%
5Y*
-43.48%
10Y*
-23.69%

BLUE

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EDIT vs. BLUE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EDIT
EDIT Risk / Return Rank: 7575
Overall Rank
EDIT Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
EDIT Sortino Ratio Rank: 8282
Sortino Ratio Rank
EDIT Omega Ratio Rank: 7575
Omega Ratio Rank
EDIT Calmar Ratio Rank: 7373
Calmar Ratio Rank
EDIT Martin Ratio Rank: 6868
Martin Ratio Rank

BLUE
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EDIT vs. BLUE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and bluebird bio, Inc. (BLUE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EDITBLUEDifference

Sharpe ratio

Return per unit of total volatility

1.16

Sortino ratio

Return per unit of downside risk

2.16

Omega ratio

Gain probability vs. loss probability

1.24

Calmar ratio

Return relative to maximum drawdown

1.63

Martin ratio

Return relative to average drawdown

3.10

EDIT vs. BLUE - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


EDITBLUEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.47

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.28

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.21

Correlation

The correlation between EDIT and BLUE is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

EDIT vs. BLUE - Dividend Comparison

Neither EDIT nor BLUE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

EDIT vs. BLUE - Drawdown Comparison


Loading graphics...

Drawdown Indicators


EDITBLUEDifference

Max Drawdown

Largest peak-to-trough decline

-98.92%

Max Drawdown (1Y)

Largest decline over 1 year

-59.88%

Max Drawdown (5Y)

Largest decline over 5 years

-98.66%

Max Drawdown (10Y)

Largest decline over 10 years

-98.92%

Current Drawdown

Current decline from peak

-97.27%

Average Drawdown

Average peak-to-trough decline

-61.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.49%

Volatility

EDIT vs. BLUE - Volatility Comparison


Loading graphics...

Volatility by Period


EDITBLUEDifference

Volatility (1M)

Calculated over the trailing 1-month period

31.71%

Volatility (6M)

Calculated over the trailing 6-month period

60.26%

Volatility (1Y)

Calculated over the trailing 1-year period

98.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

93.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

83.41%

Financials

EDIT vs. BLUE - Financials Comparison

This section allows you to compare key financial metrics between Editas Medicine, Inc. and bluebird bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M60.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
24.74M
38.71M
(EDIT) Total Revenue
(BLUE) Total Revenue
Values in USD except per share items